Puli Pharmaceuticals injects vancomycin hydrochloric acid for injection is licensed to be listed in Canada.

Guide: Vancomycin hydrochloric acid is used to treat serious infections caused by sensitive strains of methicillin-resistant staphylococcus.!---- , on July 28 , Hainan Puli Pharmaceuticals announced that it had recently received a listing license from Health Canada for the injection of vancomycin hydrochloric acid .approved indications: vancomycin hydrochloric acid is used to treat serious infections caused by the sensitive strains of methicillin-resistant staphylococcus ( beta-lactame).it is applicable to patients with penicillin allergies, patients who do not accept or react to other drugs, including penicillin or cephalosporins, and infections caused by vancomycin-sensitive organisms that are resistant to other antimicrobial drugs.effective against staphylococcal endocarditis, as well as other infections caused by staphylococcus, including sepsis, myelitis, lower respiratory tract infections, skin and skin tissue infections, etc. thecompound vancomycin was first isolated from the soil by Lilly, which was approved by the FDA in 1958 and is trademarked by Vancocin ®.vancomycin is included in the Who's standard list of essential medicines.currently injected with vancomycin hydrochloric acid has been widely marketed around the world..